Search

everythinglearnresearchcommunity

for

Search:↓

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The document is a detailed medical reference on skin and genetic disorders.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Somatostatin may help protect hair follicles from immune attacks.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.